Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'F-18 DOPA' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 195 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Kuopio, AM; Marttila, RJ; Helenius, H; Rinne, UK
      Familial occurrence of Parkinson's disease in a community-based case-control study

      PARKINSONISM & RELATED DISORDERS
    2. Thobois, S; Guillouet, S; Broussolle, E
      Contributions of PET and SPECT to the understanding of the pathophysiologyof Parkinson's disease

      NEUROPHYSIOLOGIE CLINIQUE-CLINICAL NEUROPHYSIOLOGY
    3. Cumming, P; Munk, OL; Doudet, D
      Loss of metabolites from monkey striatum during PET with FDOPA

      SYNAPSE
    4. Ruottinen, HM; Niinivirta, M; Bergman, J; Oikonen, V; Solin, O; Eskola, O; Eronen, E; Sonninen, P; Rinne, UK
      Detection of response to COMT inhibition in FDOPA PET in advanced Parkinson's disease requires prolonged imaging

      SYNAPSE
    5. Saletu, M; Anderer, P; Saletu, B; Hauer, C; Mandl, M; Semler, B; Saletu-Zyhlarz, G
      Sleep laboratory studies in periodic limb movement disorder (PLMD) patients as compared with normals and acute effects of ropinirole

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    6. Yee, RE; Irwin, I; Milonas, C; Stout, DB; Huang, SC; Shoghi-Jadid, K; Satyamurthy, N; Delanney, LE; Togaski, DM; Farahani, KF; Delfani, K; Janson, AM; Phelps, ME; Langston, JW; Barrio, JR
      Novel observations with FDOPA-PET imaging after early nigrostriatal damage

      MOVEMENT DISORDERS
    7. Nurmi, E; Ruottinen, HM; Bergman, J; Haaparanta, M; Solin, O; Sonninen, P; Rinne, JO
      Rate of progression in Parkinson's disease: A 6-[F-18]fluoro-L-dopa PET study

      MOVEMENT DISORDERS
    8. Ghaemi, M; Rudolf, J; Hilker, R; Herholz, K; Heiss, WD
      Increased pineal Fdopa uptake is related to severity of Parkinson's disease - A PET study

      JOURNAL OF PINEAL RESEARCH
    9. Berendse, HW; Booij, J; Francot, CMJE; Bergmans, PLM; Hijman, R; Stoof, JC; Wolters, EC
      Subclinical dopaminergic dysfunction in asymptomatic Parkinson's disease patients' relatives with a decreased sense of smell

      ANNALS OF NEUROLOGY
    10. Chan, PLS; Holford, NHG
      Drug treatment effects on disease progression

      ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
    11. Hoegerle, S; Altehoefer, C; Ghanem, N; Brink, I; Moser, E; Nitzsche, E
      F-18-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    12. Winogrodzka, A; Bergmans, P; Booij, J; van Royen, EA; Janssen, AGM; Wolters, EC
      [I-123]FP-CIT SPECT is a useful method to monitor the rate of dopaminergicdegeneration in early-stage Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION
    13. Dagher, A
      Functional imaging in Parkinson's disease

      SEMINARS IN NEUROLOGY
    14. Danielsen, EH; Smith, DF; Andersen, F; Gee, AD; Bender, D; Hansen, SB; Hermansen, F; Ostergaard, L; Cumming, P; Gjedde, A
      FDOPA metabolism in the adult porcine brain: influence of tracer circulation time and VOI selection on estimates of striatal DOPA decarboxylation

      JOURNAL OF NEUROSCIENCE METHODS
    15. Dimitrakopoulou-Strauss, A; Strauss, LG; Burger, C
      Quantitative PET studies in pretreated melanoma patients: A comparison of 6-[F-18] fluoro-L-dopa with F-18-FDG and O-15-water using compartment and noncompartment analysis

      JOURNAL OF NUCLEAR MEDICINE
    16. Doudet, DJ
      Monitoring disease progression in Parkinson's disease

      JOURNAL OF CLINICAL PHARMACOLOGY
    17. Marek, K; Innis, R; van Dyck, C; Fussell, B; Early, M; Eberly, S; Oakes, D; Seibyl, J
      [I-123]beta-CIT SPECT imaging assessment of the rate of Parkinson's disease progression

      NEUROLOGY
    18. Deguchi, K; Takeuchi, H; Sasaki, I; Tsukaguchi, M; Touge, T; Nishioka, M
      Impaired novelty P3 potentials in multiple system atrophy - correlation with orthostatic hypotension

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    19. Kaasinen, V; Nurmi, E; Bruck, A; Bergman, J; Solin, O; Rinne, JO
      Increased frontal [F-18]fluorodopa uptake in early Parkinson's Disease: sex differences in the prefrontal cortex

      BRAIN
    20. Weder, B; Azari, NP; Knorr, U; Seitz, RJ; Keel, A; Nienhusmeier, M; Maguire, RP; Leenders, KL; Ludin, HP
      Disturbed functional brain interactions underlying deficient tactile object discrimination in Parkinson's disease

      HUMAN BRAIN MAPPING
    21. Zhang, Y; Dawson, VL; Dawson, TM
      Oxidative stress and genetics in the pathogenesis of Parkinson's disease

      NEUROBIOLOGY OF DISEASE
    22. Elkashef, AM; Doudet, D; Bryant, T; Cohen, RM; Li, SH; Wyatt, RJ
      6-F-18-DOPA PET study in patients with schizophrenia

      PSYCHIATRY RESEARCH-NEUROIMAGING
    23. Ribeiro, MJ; Remy, P; Bendriem, B; Almeida, P; Brulon, V; Samson, Y; Maziere, B; Trebossen, R
      Comparison of clinical data sets acquired on different tomographs using 6-F-18-L-dopa

      EUROPEAN JOURNAL OF NUCLEAR MEDICINE
    24. Ludolph, AC
      Treatment of amyotrophic lateral sclerosis - What is the next step?

      JOURNAL OF NEUROLOGY
    25. Brucke, T; Djamshidian, S; Bencsits, G; Pirker, W; Asenbaum, S; Podreka, I
      SPECT and PET imaging of the dopaminergic system in Parkinson's disease

      JOURNAL OF NEUROLOGY
    26. Brooks, DJ
      Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease

      JOURNAL OF NEUROLOGY
    27. Laihinen, A; Ruottinen, H; Rinne, JO; Haaparanta, M; Bergman, J; Solin, O; Koskenvuo, M; Marttila, R; Rinne, UK
      Risk for Parkinson's disease: twin studies for the detection of asymptomatic subjects using [F-18]6-fluorodopa PET

      JOURNAL OF NEUROLOGY
    28. Gasser, T
      Autosomal-dominantly inherited forms of Parkinson's disease

      JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    29. Saletu, M; Anderer, P; Saletu, B; Hauer, C; Mandl, M; Oberndorfer, S; Zoghlami, A; Saletu-Zyhlarz, G
      Sleep laboratory studies in restless legs syndrome patients as compared with normals and acute effects of ropinirole 2. Findings on periodic leg movement, arousals and respiratory variables

      NEUROPSYCHOBIOLOGY
    30. Shoghi-Jadid, K; Huang, SC; Stout, DB; Yee, RE; Yeh, EL; Farahani, KF; Satyamurthy, N; Phelps, ME; Barrio, JR
      Striatal kinetic modeling of FDOPA with a cerebellar-derived constraint onthe distribution volume of 3OMFD: A PET investigation using non-human primates

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    31. Simon, O
      Place of the paraclinical exams in the Parkinson's disease: review.

      REVUE NEUROLOGIQUE
    32. Viallet, F
      Diagnostic criteria for idiopathic Parkinson's disease.

      REVUE NEUROLOGIQUE
    33. Defer, GL
      Surgical treatment: inclusion criteria

      REVUE NEUROLOGIQUE

    34. Parkinson's disease in twins - Response

      NEUROLOGY
    35. Snow, BJ; Vingerhoets, FJG; Langston, JW; Tetrud, JW; Sossi, V; Calne, DB
      Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    36. Yee, RE; Huang, SC; Stout, DB; Irwin, I; Shoghi-Jadid, K; Togaski, DM; DeLanney, LE; Langston, JW; Satyamurthy, N; Farahani, KF; Phelps, ME; Barrio, JR
      Nigrostriatal reduction of aromatic L-amino acid decarboxylase activity inMPTP-treated squirrel monkeys: In vivo and in vitro investigations

      JOURNAL OF NEUROCHEMISTRY
    37. DeJesus, OT; Haaparanta, M; Solin, O; Nickles, RJ
      6-FluoroDOPA metabolism in rat striatum: time course of extracellular metabolites

      BRAIN RESEARCH
    38. Schulz, JB; Dichgans, J
      Molecular pathogenesis of movement disorders: are protein aggregates a common link in neuronal degeneration?

      CURRENT OPINION IN NEUROLOGY
    39. Perlmutter, JS; Moerlein, SM
      PET measurements of dopaminergic pathways in the brain

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    40. Weder, BJ; Leenders, KL; Vontobel, P; Nienhusmeier, M; Keel, A; Zaunbauer, W; Vonesch, T; Ludin, HP
      Impaired somatosensory discrimination of shape in Parkinson's disease: Association with caudate nucleus dopaminergic function

      HUMAN BRAIN MAPPING
    41. Huang, SC; Quintana, J; Satyamurthy, N; Lacan, G; Yu, DC; Phelps, ME; Barrio, JR
      [F-18]fluoro-beta-fluoromethylene-m-tyrosine derivatives show stereo, geometrical, and regio specificities as in vivo central dopaminergic probes in monkeys

      NUCLEAR MEDICINE AND BIOLOGY
    42. Deep, P; Dagher, A; Sadikot, A; Gjedde, A; Cumming, P
      Stimulation of dopa decarboxylase activity in striatum of healthy human brain secondary to NMDA receptor antagonism with a low dose of amantadine

      SYNAPSE
    43. Danielsen, EH; Smith, DF; Gee, AD; Venkatachalam, TK; Hansen, SB; Hermansen, F; Gjedde, A; Cumming, P
      Cerebral 6-[F-18]fluoro-L-DOPA (FDOPA) metabolism in pig studied by positron emission tomography

      SYNAPSE
    44. Trenkwalder, C; Walters, AS; Hening, WA; Chokroverty, S; Antonini, A; Dhawan, V; Eidelberg, D
      Positron emission tomographic studies in restless legs syndrome

      MOVEMENT DISORDERS
    45. Ludolph, AC; Gerhard, A
      Neuroprotection and biological markers in neurodegenerative diseases

      NERVENHEILKUNDE
    46. Piccini, P; Burn, DJ; Ceravolo, R; Maraganore, D; Brooks, DJ
      The role of inheritance in sporadic Parkinson's disease: Evidence from a longitudinal study of dopaminergic function in twins

      ANNALS OF NEUROLOGY
    47. Ouchi, Y; Yoshikawa, E; Okada, H; Futatsubashi, M; Sekine, Y; Iyo, M; Sakamoto, M
      Alterations in binding site density of dopamine transporter in the striatum, orbitofrontal cortex, and amygdala in early Parkinson's disease: Compartment analysis for beta-CFT binding with positron emission tomography

      ANNALS OF NEUROLOGY
    48. Brooks, DJ
      Functional imaging of Parkinson's disease: is it possible to detect brain areas for specific symptoms?

      JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT
    49. Doudet, DJ; Chan, GLY; Jivan, S; DeJesus, OT; McGeer, EG; English, C; Ruth, TJ; Holden, JE
      Evaluation of dopaminergic presynaptic integrity: 6-[F-18]fluoro-L-dopa versus 6-[F-18]fluoro-L-m-tyrosine

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    50. Kim, YH; Kim, JW; Ito, KG; Lim, HS; Cheong, HK; Kim, JY; Shin, YC; Kim, KS; Moon, YH
      Idiopathic parkinsonism with superimposed manganese exposure: Utility of positron emission tomography

      NEUROTOXICOLOGY
    51. Samii, A; Markopoulou, K; Wszolek, ZK; Sossi, V; Dobko, T; Mak, E; Calne, DB; Stoessl, AJ
      PET studies of parkinsonism associated with mutation in the alpha-synuclein gene

      NEUROLOGY
    52. Brown, WD; Taylor, MD; Roberts, AD; Oakes, TR; Schueller, MJ; Holden, JE; Malischke, LM; DeJesus, OT; Nickles, RJ
      FluoroDOPA PET shows the nondopaminergic as well as dopaminergic destinations of levodopa

      NEUROLOGY
    53. Berg, D; Becker, G; Zeiler, B; Tucha, O; Hofmann, E; Preier, M; Benz, P; Jost, W; Reiners, K; Lange, KW
      Vulnerability of the nigrostriatal system as detected by transcranial ultrasound

      NEUROLOGY
    54. Vieregge, P; Hagenah, J; Heberlein, I; Klein, C; Ludin, HP
      Parkinson's disease in twins - A follow-up study

      NEUROLOGY
    55. Lee, MS; Kim, YD; Im, JH; Kim, HJ; Rinne, JO; Bhatia, KP
      I-123-IPT brain SPECT study in essential tremor and Parkinson's disease

      NEUROLOGY
    56. Bhatt, MH; Elias, MA; Mankodi, AK
      Acute and reversible parkinsonism due to organophosphate pesticide intoxication - Five cases

      NEUROLOGY
    57. Heiss, WD; Wurker, M
      Value of functional imaging in Parkinson's disease and related movement disorders

      NERVENARZT
    58. Broussolle, E; Dentresangle, C; Landais, P; Garcia-Larrea, L; Pollak, P; Croisile, B; Hibert, O; Bonnefoi, F; Galy, G; Froment, JC; Comar, D
      The relation of putamen and caudate nucleus F-18-Dopa uptake to motor and cognitive performances in Parkinson's disease

      JOURNAL OF THE NEUROLOGICAL SCIENCES
    59. Ito, K; Morrish, PK; Rakshi, JS; Uema, T; Ashburner, J; Bailey, DL; Friston, KJ; Brooks, DJ
      Statistical parametric mapping with F-18-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson's disease

      JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
    60. Stoof, JC; Winogrodzka, A; van Muiswinkel, FL; Wolters, EC; Voorn, P; Groenewegen, HJ; Booij, J; Drukarch, B
      Leads for the development of neuroprotective treatment in Parkinson's disease and brain imaging methods for estimating treatment efficacy

      EUROPEAN JOURNAL OF PHARMACOLOGY
    61. Rakshi, JS; Uema, T; Ito, K; Bailey, DL; Morrish, PK; Ashburner, J; Dagher, A; Jenkins, IH; Friston, KJ; Brooks, DJ
      Frontal, midbrain and striatal dopaminergic function in early and advancedParkinson's disease A 3D [F-18]dopa-PET study

      BRAIN
    62. Hoegerle, S; Schneider, B; Kraft, A; Moser, E; Nitzsche, EU
      Imaging of a metastatic gastrointestinal carcinoid by F-18-DOPA positron emission tomography

      NUKLEARMEDIZIN
    63. Ilgin, N
      Functional imaging of neurotransmitter systems in movement disorders

      QUARTERLY JOURNAL OF NUCLEAR MEDICINE
    64. BROOKS DJ
      POSITRON-EMISSION-TOMOGRAPHY STUDIES IN MOVEMENT-DISORDERS

      Neurosurgery clinics of North America
    65. LEGER G; GJEDDE A; KUWABARA H; GUTTMAN M; CUMMING P
      EFFECT OF CATECHOL-O-METHYLTRANSFERASE INHIBITION ON BRAIN UPTAKE OF [F-18] FLUORODOPA - IMPLICATIONS FOR COMPARTMENTAL MODELING AND CLINICAL USEFULNESS

      Synapse
    66. ODERGREN T; STONEELANDER S; INGVAR M
      CEREBRAL AND CEREBELLAR ACTIVATION IN CORRELATION TO THE ACTION-INDUCED DYSTONIA IN WRITERS CRAMP

      Movement disorders
    67. PLAYFORD ED; PASSINGHAM RE; MARSDEN CD; BROOKS DJ
      INCREASED ACTIVATION OF FRONTAL AREAS DURING ARM MOVEMENT IN IDIOPATHIC TORSION DYSTONIA

      Movement disorders
    68. NAUMANN M; PIRKER W; REINERS K; LANGE KW; BECKER G; BRUCKE T
      IMAGING THE PRE-SYNAPTIC AND POSTSYNAPTIC SIDE OF STRIATAL DOPAMINERGIC SYNAPSES IN IDIOPATHIC CERVICAL DYSTONIA - A SPECT STUDY USING [I-123] EPIDEPRIDE AND [I-123] BETA-CIT

      Movement disorders
    69. DEUSCHL G; BAIN P; BRIN M
      CONSENSUS STATEMENT OF THE MOVEMENT DISORDER SOCIETY ON TREMOR

      Movement disorders
    70. BOECKER H; BROOKS DJ
      FUNCTIONAL IMAGING OF TREMOR

      Movement disorders
    71. FAHN S; ELLIOTT R
      HIGHLIGHTS OF THE PARKINSONS-DISEASE-FOUNDATION

      Movement disorders
    72. BROOKS DJ
      THE EARLY DIAGNOSIS OF PARKINSONS-DISEASE

      Annals of neurology
    73. GASSER T
      GENETICS OF PARKINSONS-DISEASE

      Annals of neurology
    74. DOLLE F; DEMPHEL S; HINNEN F; FOURNIER D; VAUFREY F; CROUZEL C
      6-[F-18]FLUORO-L-DOPA BY RADIOFLUORODESTANNYLATION - A SHORT AND SIMPLE SYNTHESIS OF A NEW LABELING PRECURSOR

      Journal of labelled compounds & radiopharmaceuticals
    75. MESSA C; VOLONTE MA; FAZIO F; ZITO F; CARPINELLI A; DAMICO A; RIZZO G; MORESCO RM; PAULESU E; FRANCESCHI M; LUCIGNANI G
      DIFFERENTIAL DISTRIBUTION OF STRIATAL [(123)L]BETA-CIT IN PARKINSONS-DISEASE AND PROGRESSIVE SUPRANUCLEAR PALSY, EVALUATED WITH SINGLE-PHOTON EMISSION TOMOGRAPHY

      European journal of nuclear medicine
    76. TREBOSSEN R; BENDRIEM B; RIBEIRO MJ; FONTAINE A; FROUIN V; REMY P
      VALIDATION OF THE 3-DIMENSIONAL ACQUISITION MODE IN POSITRON-EMISSION-TOMOGRAPHY FOR THE QUANTITATION OF [F-18] FLUORO-DOPA UPTAKE IN THE HUMAN STRIATA

      Journal of cerebral blood flow and metabolism
    77. STOUT DB; HUANG SC; MELEGA WP; RALEIGH MJ; PHELPS ME; BARRIO JR
      EFFECTS OF LARGE NEUTRAL AMINO-ACID-CONCENTRATIONS ON 6-[F-18]FLUORO-L-DOPA KINETICS

      Journal of cerebral blood flow and metabolism
    78. Huang, SC; Stout, DB; Yee, RE; Satyamurthy, N; Barrio, JR
      Distribution volume of radiolabeled large neutral amino acids in brain tissue

      JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
    79. BROWN WD; OAKES TR; DEJESUS OT; TAYLOR MD; ROBERTS AD; NICKLES RJ; HOLDEN JE
      FLUORINE-18-FLUORO-L-DOPA DOSIMETRY WITH CARBIDOPA PRETREATMENT

      The Journal of nuclear medicine
    80. GASSER T
      GENETICS OF PARKINSONS-DISEASE

      Clinical genetics
    81. BERARDELLI A; ROTHWELL JC; HALLETT M; THOMPSON PD; MANFREDI M; MARSDEN CD
      THE PATHOPHYSIOLOGY OF PRIMARY DYSTONIA

      Brain (Print)
    82. WANG RF; LOCH C; MAZIERE B
      DETERMINATION OF UNCHANGED [F-18] DOPAMINE IN HUMAN AND NONHUMAN PRIMATE PLASMA DURING POSITRON EMISSION TOMOGRAPHY STUDIES - A NEW SOLID-PHASE EXTRACTION METHOD COMPARABLE TO RADIO-THIN-LAYER CHROMATOGRAPHY ANALYSIS

      Journal of chromatography B. Biomedical sciences and applications
    83. MORRISH PK; RAKSHI JS; BROOKS DJ
      CAN THE NEUROPROTECTIVE EFFICACY OF AN AGENT EVER BE CONCLUSIVELY PROVEN

      European journal of neurology
    84. BROOKS DJ
      ADVANCES IN IMAGING PARKINSONS-DISEASE - EDITORIAL REVIEW

      Current opinion in neurology
    85. BERGSTROM M; LU L; MARQUEZ M; FASTH KJ; BJURLING P; WATANABE Y; ERIKSSON B; LANGSTROM B
      MODULATION OF ORGAN UPTAKE OF C-11 LABELED L-DOPA

      Nuclear medicine and biology
    86. QUINN NP
      PARKINSONS-DISEASE - CLINICAL-FEATURES

      Bailliere's clinical neurology
    87. WOOD N
      GENETIC-ASPECTS OF PARKINSONISM

      Bailliere's clinical neurology
    88. BROOKS DJ
      PET AND SPECT STUDIES IN PARKINSONS-DISEASE

      Bailliere's clinical neurology
    89. DAOCASTELLANA MH; PAILLEREMARTINOT ML; HANTRAYE P; ATTARLEVY D; REMY P; CROUZEL C; ARTIGES E; FELINE A; SYROTA A; MARTINOT JL
      PRESYNAPTIC DOPAMINERGIC FUNCTION IN THE STRIATUM OF SCHIZOPHRENIC-PATIENTS

      Schizophrenia research
    90. MORRISH PK
      PARKINSONS-DISEASE IS NOT A LONG-LATENCY ILLNESS

      Movement disorders
    91. TURJANSKI N; PENTLAND B; LEES AJ; BROOKS DJ
      PARKINSONISM ASSOCIATED WITH ACUTE INTRACRANIAL HEMATOMAS - AN [F-18]DOPA POSITRON-EMISSION-TOMOGRAPHY STUDY

      Movement disorders
    92. PICCINI P; MORRISH PK; TURJANSKI N; SAWLE GV; BURN DJ; WEEKS RA; MARK MH; MARAGANORE DM; LEES AJ; BROOKS DJ
      DOPAMINERGIC FUNCTION IN FAMILIAL PARKINSONS-DISEASE - A CLINICAL ANDF-18 DOPA POSITRON EMISSION TOMOGRAPHY STUDY

      Annals of neurology
    93. WALKER Z; COSTA DC; JANSSEN AG; WALKER RWH; LIVINGSTONE G; KATONA CLE
      DEMENTIA WITH LEWY BODIES - A STUDY OF POSTSYNAPTIC DOPAMINERGIC RECEPTORS WITH I-123 IODOBENZAMIDE SINGLE-PHOTON EMISSION TOMOGRAPHY

      European journal of nuclear medicine
    94. TATSCH K; SCHWARZ J; MOZLEY PD; LINKE R; POGARELL O; OERTEL WH; FIEBER RS; HAHN K; KUNG HF
      RELATIONSHIP BETWEEN CLINICAL-FEATURES OF PARKINSONS-DISEASE AND PRESYNAPTIC DOPAMINE TRANSPORTER BINDING ASSESSED WITH [I-123] IPT AND SINGLE-PHOTON EMISSION TOMOGRAPHY

      European journal of nuclear medicine
    95. BRUCKE T; ASENBAUM S; PIRKER W; DJAMSHIDIAN S; WENGER S; WOBER C; MULLER C; PODREKA I
      MEASUREMENT OF THE DOPAMINERGIC DEGENERATION IN PARKINSONS-DISEASE WITH [I-123] BETA-CIT AND SPECT - CORRELATION WITH CLINICAL FINDINGS ANDCOMPARISON WITH MULTIPLE SYSTEM ATROPHY AND PROGRESSIVE SUPRANUCLEAR PALSY

      Journal of neural transmission. Supplementum
    96. SALMON E
      POSITRON-EMISSION-TOMOGRAPHY IN PARKINSONISM

      Acta neurologica belgica
    97. RAUCH SL; SAVAGE CR
      NEUROIMAGING AND NEUROPSYCHOLOGY OF THE STRIATUM - BRIDGING BASIC SCIENCE AND CLINICAL-PRACTICE

      The Psychiatric clinics of North America
    98. MISHIMA Y; IMAHORI Y; HONDA C; HIRATSUKA J; UEDA S; IDO T
      IN-VIVO DIAGNOSIS OF HUMAN-MALIGNANT MELANOMA WITH POSITRON EMISSION TOMOGRAPHY USING SPECIFIC MELANOMA-SEEKING F-18 DOPA ANALOG

      Journal of neuro-oncology
    99. DEEP P; KUWABARA H; GJEDDE A; CUMMING P
      THE KINETIC-BEHAVIOR OF [H-3]DOPA IN LIVING RAT-BRAIN INVESTIGATED BYCOMPARTMENTAL MODELING OF STATIC AUTORADIOGRAMS

      Journal of neuroscience methods
    100. DOUDET DJ; CHAN GLY; HOLDEN JE; MORRISON KS; WYATT RJ; RUTH TJ
      EFFECTS OF CATECHOL-O-METHYLTRANSFERASE INHIBITION ON THE RATES OF UPTAKE AND REVERSIBILITY OF 6-FLUORO-L-DOPA TRAPPING IN MPTP-INDUCED PARKINSONISM IN MONKEYS

      Neuropharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 11/08/20 alle ore 23:48:21